Biocept Inc logo

BIOC - Biocept Inc News Story

$4.61 0.2  3.7%

Last Trade - 07/05/21

Sector
Healthcare
Size
Micro Cap
Market Cap £42.9m
Enterprise Value £34.3m
Revenue £19.8m
Position in Universe 5527th / 6850

BRIEF-Biocept Q3 Loss Per Share $2.42

Tue 13th November, 2018 9:22pm
Biocept Inc  BIOC.O :
    * BIOCEPT REPORTS THIRD QUARTER 2018 FINANCIAL RESULTS
    * Q3 LOSS PER SHARE $2.42
    * Q3 REVENUE $762,000 VERSUS I/B/E/S VIEW $948,000
    * Q3 EARNINGS PER SHARE VIEW $-2.02 -- THOMSON REUTERS
I/B/E/S
    * CASH AND CASH EQUIVALENTS AS OF SEPTEMBER 30, 2018 WERE
$9.0
MILLION, COMPARED WITH $2.1 MILLION AS OF DECEMBER 31, 2017

Source text for Eikon:  ID:nPn1pXbJWa 
Further company coverage:  BIOC.O
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.